EXPRESS: 不安睡眠を超えて: 阻害性睡眠時無呼吸リスク,老化バイオマーカー,および慢性腰痛の横断的な研究

Khalid Walid Freij1, Fiona Agbor1, Philemon Domoyeri1

  • 1Department of Acute, Chronic, & Continuing Care, Nurse Anesthesia Program, School of Nursing, The University of Alabama at Birmingham, Birmingham, AL, USA.

Molecular pain
|February 17, 2026
PubMed
まとめ

阻害性睡眠時無呼吸 (OSA) のリスクは,より急速な生物学的老化と慢性腰痛 (CLBP) と関連しています. OSAを治療すると,痛みや老化を改善することがあります.

関連する概念動画

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
605
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.2K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
244